British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

  title={British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update},
  author={Sue J. Wilson and Kirstie N. Anderson and David S. Baldwin and Derk-Jan Dijk and Audrey Espie and Colin A. Espie and Paul Gringras and Andrew D. Krystal and David J. Nutt and Hugh Selsick and Ann L. Sharpley},
  journal={Journal of Psychopharmacology},
  pages={923 - 947}
This British Association for Psychopharmacology guideline replaces the original version published in 2010, and contains updated information and recommendations. A consensus meeting was held in London in October 2017 attended by recognised experts and advocates in the field. They were asked to provide a review of the literature and identification of the standard of evidence in their area, with an emphasis on meta-analyses, systematic reviews and randomised controlled trials where available, plus… 

Figures and Tables from this paper

[Evaluation and management of insomnia in clinical practice and in the time of CoViD-19 in Italy: expert consensus and task-force recommendations from five scientific societies].

Insomnia symptoms might affect about 60% of the Italian population. Insomnia is a "24 hours syndrome" and a risk factor for medical and mental disorders. It should always be assessed and treated in

Expert Opinions and Consensus Recommendations for the Evaluation and Management of Insomnia in Clinical Practice: Joint Statements of Five Italian Scientific Societies

It is suggested that symptoms of insomnia must always be assessed in the Italian clinical practice by evaluating nocturnal and daytime symptoms, comorbid conditions and lifestyle.

Systematic Review of Clinical Practice Guidelines for Insomnia Disorder

Indications for starting medications are the only common thread in all of the reviewed CPGs, and most of the C PGs did not provide recommendations on all subsequent clinical considerations.

Sleep and schizophrenia: From epiphenomenon to treatable causal target

Listening to music for insomnia in adults.

Low-certainty evidence is found that, compared to no treatment or TAU, listening to music may reduce problems with sleep-onset latency and improve sleep quality in adults with insomnia, and this Cochrane Review is an update of a review published in 2015.


Cognitive behavioural therapy for insomnia has shown durable long-term effects after treatment discontinuation and Administering a combined treatment of CBT-I and medication could decrease the latency to treatment response, but might diminish the durability of the positive treatment effects of CBt-I.

Perampanel in chronic insomnia

Biological rhythms and chronotherapeutics in depression

International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders

The administration of prolonged release melatonin at 2–10 mg, 1–2 h before bedtime, might be used in the treatment of insomnia symptoms or comorbid insomnia in mood disorders, schizophrenia, in adults with autism spectrum disorders, neurocognitive disorders and during sedative-hypnotics discontinuation.



British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders

These British Association for Psychopharmacology guidelines are designed to address this problem by providing an accessible up-to-date and evidence-based outline of the major issues, especially those relating to reliable diagnosis and appropriate treatment.

European guideline for the diagnosis and treatment of insomnia

This European guideline for the diagnosis and treatment of insomnia was developed by a task force of the European Sleep Research Society, with the aim of providing clinical recommendations for the

EFNS guidelines on management of narcolepsy

A task force composed of the leading specialists of narcolepsy in Europe conducted an extensive review of pharmacological and behavioral trials available in the literature to reinforce the use of those drugs evaluated in randomized placebo‐controlled trials and to reach a consensus, as much as possible, on theUse of other available medications.

Treatments for somnambulism in adults: assessing the evidence.

Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians.

This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015 and recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder.

Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.

CONTEXT Insomnia is a prevalent health complaint associated with daytime impairments, reduced quality of life, and increased health-care costs. Although it is often self-treated with herbal and

Quetiapine for insomnia: A review of the literature.

Given its limited efficacy data, its adverse-effect profile, and the availability of agents approved by the Food and Drug Administration for the treatment of insomnia, quetiapine's benefit in the Treatment of insomnia has not been proven to outweigh potential risks, even in patients with a comorbid labeled indication.

Insomnia (primary) in older people: non-drug treatments.

In this systematic review, information relating to the effectiveness and safety of the following interventions are presented: cognitive behavioural therapy for insomnia (CBT-I), exercise programmes, and timed exposure to bright light.

The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTs

Benzodiazepines and non-benzodiazepine treatments for chronic insomnia are effective treatments in the management of chronic insomnia, although they pose a risk of harm.

Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults.

  • C. Espie
  • Psychology
    Annual review of psychology
  • 2002
It is proposed that sleep homeostatic and circadian factors are compromised by impairment of the automaticity and plasticity associated with good sleep, and that cognitive/affective processes activate the clinical complaint of insomnia.